Influence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review

BACKGROUND: Hyperphosphatemia is one of the common complications in patients undergoing hemodialysis. Although calcium carbonate (CaC) is often used to control serum inorganic phosphorus level in dialysis patients, co-administration of gastric acid reducers (ARs) may interfere with the phosphate bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsuzawa, Masaomi, Ogawa, Ryuichi, Ohkubo, Atsushi, Shimojima, Kazuyo, Maeda, Kunimi, Echizen, Hirotoshi, Miyazaki, Akihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120546/
https://www.ncbi.nlm.nih.gov/pubmed/27895933
http://dx.doi.org/10.1186/s40780-016-0068-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120546/
https://www.ncbi.nlm.nih.gov/pubmed/27895933
http://dx.doi.org/10.1186/s40780-016-0068-1

Ejemplares similares